title: Severe RSV disease in preterm infants born at 29 to 35 weeks' gestation in the United States.
authors.affiliation: Vice PresidentInfectious Disease, US Medical Affairs, AstraZeneca.
authors.forename: Christopher S
authors.initials: CS
authors.lastname: Ambrose
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D006801:Humans; D018357:Respiratory Syncytial Virus Infections / Q000517:prevention & control*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents